drugset / Trial / NCT07014059

Autologous Serum Obtained by a Closed-Circuit Collection Device

NCT07014059

Phase 2 Not yet recruiting 16 enrolled GIANCARLO FATOBENE JP Farma · collab
NaSingle-groupOpen-labelTreatment

Summary

Autologous serum eye drops (ASED) are an established therapy for ocular surface diseases; however, their preparation can be costly and may not be available due to the need for germ-free conditions. This pilot trial assesses the feasibility of collecting ASED in a closed-circuit system for patients with chronic ocular surface diseases.

Timeline

Start
2025-06-20
Primary completion
2026-06-20
Completion
2027-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous serum Unknown 20 % Topical